文献速递神经介入DSACT

使用PHIL液体栓塞剂栓塞颅内硬脑膜动静脉瘘26例:多中心研究

Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study.
PubMed 文献 · AJNR Am J Neuroradiol · 2016-12-08

回顾性多中心研究纳入26例颅内硬脑膜动静脉瘘患者,采用PHIL液体栓塞剂单独或联合其他栓塞材料治疗,即刻完全血管造影闭塞率为77%(20/26),1例出现引流静脉急性血栓导致原有共济失调加重。作者认为PHIL似乎安全有效,短期结果与Onyx相当,且准备更简便、铸型显影更均匀、CT伪影更少。

要点

  • PHIL栓塞颅内硬脑膜动静脉瘘即刻完全闭塞率为77%(20/26)。
  • 6例残留瘘中3例再次用PHIL治疗,1例达到血管造影治愈。
  • 1例出现引流静脉急性血栓致原有共济失调加重的不良事件。

核心结论

  • PHIL似乎对颅内硬脑膜动静脉瘘的血管内治疗安全有效。
  • 短期血管造影和临床结果与Onyx相当,并具有准备更简便和铸型显影更均匀的优势。
  • 使用碘作为不透射线剂相比钽基栓塞材料在CT上产生的伪影明显更少。

研究设计与样本

  • 回顾性多中心研究,纳入26例连续颅内硬脑膜动静脉瘘患者(初发或既往治疗过)。
  • 患者接受仅注射PHIL或PHIL联合其他栓塞产品(如Onyx或可解脱弹簧圈)治疗。
  • 招募时间从2014年8月开始至2015年9月结束。
  • 主要终点为硬脑膜动静脉瘘完全闭塞率;次要终点包括不良事件发生率和3个月随访时的临床状态。

诊断标准与关键数值

  • 22例(85%)患者仅用PHIL治疗,3例用PHIL联合Onyx,1例用PHIL联合弹簧圈。
  • 即刻完全血管造影闭塞在20例(77%)患者中实现。
  • 6例残留瘘患者中3例再次用PHIL治疗,其中1例达到血管造影治愈。

临床应用与阅片要点

  • 作者认为PHIL似乎安全有效,短期血管造影和临床结果与Onyx相当。
  • 作者指出PHIL具有准备更简便和铸型显影更均匀的优势。
  • 作者指出使用碘作为不透射线剂相比钽基栓塞材料在CT上产生的伪影明显更少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The introduction of liquid embolic agents has revolutionized endovascular approach to cranial vascular malformations. The aim of the study was to retrospectively assess the efficacy and safety of Precipitating Hydrophobic Injectable Liquid (PHIL), a new nonadhesive liquid embolic agent, in the treatment of patients with cranial dural arteriovenous fistulas. The primary end point was the rate of complete occlusion of dural arteriovenous fistulas. Secondary end points included the incidence of adverse events and clinical status at 3-month follow-up.

MATERIALS AND METHODS: This was a retrospective multicenter study. Twenty-six consecutive patients with dural arteriovenous fistulas (de novo or previously treated) treated by injection of PHIL only or with PHIL in combination with other embolization products (such as Onyx or detachable coils) were included in the study. Recruitment started in August 2014 and ended in September 2015.

RESULTS: Twenty-two (85%) patients were treated with PHIL only, with 3 patients treated with both PHIL and Onyx, and 1, with both PHIL and coils. Immediate complete angiographic occlusion was achieved in 20 (77%) patients. Of the 6 patients with residual fistulas, 3 were retreated with PHIL and 1 achieved angiographic cure. An adverse event was seen in 1 patient who developed worsening of preexisting ataxia due to acute thrombosis of the draining vein.

CONCLUSIONS: PHIL appears to be safe and effective for endovascular treatment of cranial dural arteriovenous fistulas. Short-term angiographic and clinical results are comparable with those of Onyx, with the added advantage of easier preparation and improved homogeneous cast visualization. The use of iodine as a radio-opacifier also produces considerably less artifacts on CT compared with tantalum-based embolic materials.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Lamin S, Chew HS, Chavda S, et al. Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study. AJNR Am J Neuroradiol. 2016. PMID: 27932510. doi:10.3174/ajnr.A5037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。